Previously, montelukast used in the maintenance treatment of asthma and to relieve symptoms of seasonal allergies has been proved to exert a protective effect on neonatal rats with HI by increasing the expression level of telomerase reverse transcriptase and Bcl-2 [32]. The gene discussed is BCL2; the disease is Allergy.